Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Clinical trial NCT05485766 · RECRUITING

Trial details

NCT number: NCT05485766
Sponsor: Okayama University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Neoplasms Triple Negative Breast Cancer Breast Neoplasms Breast Cancer BRCA1 Mutation BRCA2 Mutation BRCA Mutation BRCA-Associated Breast Carcinoma

Start date: 2024-07-16
Primary completion: 2028-06-30
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.